BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 36497170)

  • 1. Reduced MHC Class I and II Expression in HPV-Negative vs. HPV-Positive Cervical Cancers.
    Evans AM; Salnikov M; Tessier TM; Mymryk JS
    Cells; 2022 Dec; 11(23):. PubMed ID: 36497170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HPV-Positive and -Negative Cervical Cancers Are Immunologically Distinct.
    Evans AM; Salnikov M; Gameiro SF; Maleki Vareki S; Mymryk JS
    J Clin Med; 2022 Aug; 11(16):. PubMed ID: 36013065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of Class I Major Histocompatibility Complex Gene Transcription in Human Tumors Caused by Human Papillomavirus Infection.
    Gameiro SF; Zhang A; Ghasemi F; Barrett JW; Nichols AC; Mymryk JS
    Viruses; 2017 Sep; 9(9):. PubMed ID: 28891951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human leukocyte antigens I and II haplotypes associated with human papillomavirus 16-positive invasive cervical cancer in Mexican women.
    Hernández-Hernández DM; Cerda-Flores RM; Juárez-Cedillo T; Granados-Arriola J; Vargas-Alarcón G; Apresa-García T; Alvarado-Cabrero I; García-Carrancá A; Salcedo-Vargas M; Mohar-Betancourt A
    Int J Gynecol Cancer; 2009 Aug; 19(6):1099-106. PubMed ID: 19820376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HPV 16 infection and progression of cervical intra-epithelial neoplasia: analysis of HLA polymorphism and HPV 16 E6 sequence variants.
    Bontkes HJ; van Duin M; de Gruijl TD; Duggan-Keen MF; Walboomers JM; Stukart MJ; Verheijen RH; Helmerhorst TJ; Meijer CJ; Scheper RJ; Stevens FR; Dyer PA; Sinnott P; Stern PL
    Int J Cancer; 1998 Oct; 78(2):166-71. PubMed ID: 9754647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of human leukocyte antigen associations in human papillomavirus-positive and -negative head and neck cancer: Comparison with cervical cancer.
    Ekanayake Weeramange C; Shu D; Tang KD; Batra J; Ladwa R; Kenny L; Vasani S; Frazer IH; Dolcetti R; Ellis JJ; Sturm RA; Leo P; Punyadeera C
    Cancer; 2022 May; 128(10):1937-1947. PubMed ID: 35176174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating human papillomavirus type 16 specific T-cells are associated with HLA Class I expression on tumor cells, but not related to the amount of viral oncogene transcripts.
    de Boer MA; Jordanova ES; van Poelgeest MI; van den Akker BE; van der Burg SH; Kenter GG; Fleuren GJ
    Int J Cancer; 2007 Dec; 121(12):2711-5. PubMed ID: 17724722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-risk human papillomavirus E7 expression reduces cell-surface MHC class I molecules and increases susceptibility to natural killer cells.
    Bottley G; Watherston OG; Hiew YL; Norrild B; Cook GP; Blair GE
    Oncogene; 2008 Mar; 27(12):1794-9. PubMed ID: 17828295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
    Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM
    Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamics of selected MHC class I and II molecule expression in the course of HPV positive CIN treatment with the use of human recombinant IFN-gamma.
    Sikorski M; Bobek M; Zrubek H; Marcinkiewicz J
    Acta Obstet Gynecol Scand; 2004 Mar; 83(3):299-307. PubMed ID: 14995928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentially expressed genes between high-risk human papillomavirus types in human cervical cancer cells.
    Vazquez-Ortiz G; García JA; Ciudad CJ; Noé V; Peñuelas S; López-Romero R; Mendoza-Lorenzo P; Piña-Sánchez P; Salcedo M
    Int J Gynecol Cancer; 2007; 17(2):484-91. PubMed ID: 17309674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of MHC Class I Expression in HPV-associated Cervical and Vulvar Neoplasia: A Potential Mechanism of Resistance to Checkpoint Inhibition.
    Dibbern ME; Bullock TN; Jenkins TM; Duska LR; Stoler MH; Mills AM
    Am J Surg Pathol; 2020 Sep; 44(9):1184-1191. PubMed ID: 32496434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of Human Papillomavirus Genotypes Among Women With High-Grade Cervical Lesions in Beijing, China.
    Xiao M; Xu Q; Li H; Gao H; Bie Y; Zhang Z
    Medicine (Baltimore); 2016 Jan; 95(3):e2555. PubMed ID: 26817906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-DRB1*1602 allele is positively associated with HPV cervical infection in Bolivian Andean women.
    Cervantes J; Lema C; Valentina Hurtado L; Andrade R; Hurtado Gomez L; Torrico L; Zegarra L; Quiroga G; Asturizaga D; Dulon A; Prada R; Panoso W; Yashiki S; Fujiyoshi T; Sonoda S
    Hum Immunol; 2003 Sep; 64(9):890-5. PubMed ID: 12941545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are 20 human papillomavirus types causing cervical cancer?
    Arbyn M; Tommasino M; Depuydt C; Dillner J
    J Pathol; 2014 Dec; 234(4):431-5. PubMed ID: 25124771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus genotypes among females in Mexico: a study from the Mexican institute for social security.
    Salcedo M; Pina-Sanchez P; Vallejo-Ruiz V; Monroy-Garcia A; Aguilar-Lemarroy A; Cortes-Gutierrez EI; Santos-Lopez G; Montoya-Fuentes H; Grijalva R; Madrid-Marina V; Apresa-Garcia T; Hernandez DM; Jave-Suarez LF; Romero P; Poot A; Salgado E; Ramos-Gonzalez P; Gonzalez-Hernandez R; Canton JC; Jimenez-Aranda L; Parra-Melquiadez M; Paniagua L; Mendoza M; Arreola H; Villegas V; Torres-Poveda K; Bahena-Roman M; Gonzalez-Yebra B; Taniguchi K; Rodea C; Mantilla-Morales A; Mora-Garcia ML; Velazquez-Velazquez CK; Cordova-Uscanga C; Peralta R; Lopez-Romero R; Marrero D; Bandala C; Reyes-Leyva J; Furuya ME; Almeida E; Galvan ME; Grijalva I
    Asian Pac J Cancer Prev; 2014; 15(23):10061-6. PubMed ID: 25556426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P16 and HPV Genotype Significance in HPV-Associated Cervical Cancer-A Large Cohort of Two Tertiary Referral Centers.
    da Mata S; Ferreira J; Nicolás I; Esteves S; Esteves G; Lérias S; Silva F; Saco A; Cochicho D; Cunha M; Del Pino M; Ordi J; Félix A
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33669021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiation-enhanced expression of E6/E7 transforming oncogenes of human papillomavirus-16 in human cervical carcinoma.
    Santin AD; Hermonat PL; Ravaggi A; Chiriva-Internati M; Pecorelli S; Parham GP
    Cancer; 1998 Dec; 83(11):2346-52. PubMed ID: 9840534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA expression in pre-invasive cervical neoplasia in relation to human papilloma virus infection.
    Glew SS; Connor ME; Snijders PJ; Stanbridge CM; Buckley CH; Walboomers JM; Meijer CJ; Stern PL
    Eur J Cancer; 1993; 29A(14):1963-70. PubMed ID: 8280490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serine/threonine kinases 31(STK31) may be a novel cellular target gene for the HPV16 oncogene E7 with potential as a DNA hypomethylation biomarker in cervical cancer.
    Yin FF; Wang N; Bi XN; Yu X; Xu XH; Wang YL; Zhao CQ; Luo B; Wang YK
    Virol J; 2016 Apr; 13():60. PubMed ID: 27044426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.